ScienceDex / Researcher record
Medeiros, Michelle
- University of Maryland Baltimore (no department on record)
From the FY2019 NIH awards this investigator leads as contact PI. The department is the award's.
- Early Career
NIH Funding · FY2019
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2017 | $2,862,677 | 1 | #1,474 |
| 2018 | $2,314,767 | 1 | #2,250 |
| 2019 | $191 | 1 | #45,441 |
| 2022 | $537,930 | 1 | #21,621 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20171 record
- FY20181 record
- FY2019 · selected1 record
- FY20221 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2017 through FY2022Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2019 award records by amount
NIH award records listing Medeiros, Michelle as a PI. Multi-PI records show the full award amount for context.
- 272201300022I-1-27200022-1N01Contact PIVaccine and Treatment Evaluation Unit:Phase II Pertussis Vaccine Trial$191award amount
Award organization
Organizations that administered FY2019 awards listing Medeiros, Michelle as a PI.
FY2019 award administered by University of Maryland Baltimore (MD).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2017First NIH AwardUniversity of Maryland Baltimore
- 2017$500K Cumulative Funding
- 2017$1M Cumulative Funding
- 2017$2M Cumulative Funding
- 2017Entered Top 50% NationallyRanked #1474
- 2017Entered Top 25% NationallyRanked #1474
- 2017Entered Top 10% NationallyRanked #1474
- 2018$5M Cumulative Funding